Compounds > elliptinium
Page last updated: 2024-08-23

elliptinium and Anemia, Hemolytic, Acquired

elliptinium has been researched along with Anemia, Hemolytic, Acquired in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alberici, GF; Bohuon, C; Dessaux, JJ; Pallardy, M1
Alberici, GF; Bidart, JM; Bohuon, C; Caille, P; Einzig, AI; Goodman, A; Gralla, RJ; Mondesir, JM; Rouesse, J; Troalen, F1

Other Studies

2 other study(ies) available for elliptinium and Anemia, Hemolytic, Acquired

ArticleYear
Polyclonal antibodies to elliptinium acetate: structure-activity relationships and comparison with human anti-elliptinium IgM.
    International journal of immunopharmacology, 1987, Volume: 9, Issue:2

    Topics: Alkaloids; Anemia, Hemolytic; Animals; Cross Reactions; Ellipticines; Humans; Immunoglobulin G; Immunoglobulin M; Rabbits; Structure-Activity Relationship

1987
Drug-induced antibodies during 2-N-methyl-9-hydroxyellipticinium acetate (NSC-264137) treatment: schedule dependency and relationship to hemolysis.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985, Volume: 3, Issue:5

    Topics: Alkaloids; Anemia, Hemolytic; Antibodies; Breast Neoplasms; Ellipticines; Female; Humans; Prospective Studies; Retrospective Studies; Risk

1985